MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept Retained Earnings 2011-2026 | VERO
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -309 M | -262 M | -224 M | -180 M | -157 M | -75.7 M | -193 M | -164 M | -147 M | -125 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -75.7 M | -309 M | -184 M |
Quarterly Retained Earnings Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -356 M | -333 M | -321 M | -309 M | -301 M | -292 M | -272 M | -262 M | -251 M | -242 M | -234 M | -224 M | -214 M | -200 M | -189 M | -180 M | -176 M | -166 M | -167 M | -157 M | -157 M | -157 M | -157 M | -75.7 M | -75.7 M | -75.7 M | -75.7 M | -35.1 M | -193 M | -193 M | -193 M | -164 M | -164 M | -164 M | -164 M | -147 M | -147 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -35.1 M | -356 M | -194 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.07 | 0.33 % | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 171.87 | 0.74 % | $ 12.9 B | USA |
 |
AxoGen
AXGN
|
-307 M | $ 32.64 | -5.23 % | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.13 | 0.49 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.74 | -0.05 % | $ 5.47 K | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 62.59 | -0.37 % | $ 92.7 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 10.97 | 1.29 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | - | - | $ 1.06 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.38 | 0.11 % | $ 266 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.7 | 0.73 % | $ 347 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.19 | 0.17 % | $ 47.5 B | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 23.61 | 1.37 % | $ 200 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.6 | 0.05 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 88.6 | 0.77 % | $ 12 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.9 | 2.15 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.36 | 2.42 % | $ 169 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 54.14 | -1.55 % | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.0 | 1.66 % | $ 16.9 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 95.66 | -0.59 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 85.63 | -1.4 % | $ 2.97 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |